Besides inducing tumor cell proliferation, survival, migration, and drug resistance, these alterations trigger changes in the tumor microenvironment, tumor angiogenesis in particular, via upregulation of VEGF as well as deregulation of other molecules including EGFR and COX2. Here, PTGS2 is linked to neoplasm.